Qian Ma Selected Research

perfluoro-15-crown-5-ether

1/2022

Acid-Triggered H2O2 Self-Supplying Nanoplatform for 19F-MRI with Enhanced Chemo-Chemodynamic Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qian Ma Research Topics

Disease

41	Neoplasms (Cancer) 03/2022 - 06/2005
11	Inflammation (Inflammations) 03/2022 - 07/2006
8	Fibrosis (Cirrhosis) 06/2019 - 08/2016
7	Insulin Resistance 01/2022 - 12/2010
6	Myocardial Infarction 12/2021 - 09/2014
5	Body Weight (Weight, Body) 01/2022 - 02/2018
5	Stomach Neoplasms (Stomach Cancer) 01/2022 - 10/2019
5	Glioma (Gliomas) 01/2021 - 01/2015
4	Myasthenia Gravis 03/2022 - 01/2020
4	Anthrax 01/2022 - 11/2015
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 11/2014
4	Hypoxia (Hypoxemia) 01/2021 - 01/2019
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020 - 06/2014
4	Breast Neoplasms (Breast Cancer) 01/2020 - 10/2013
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 12/2016
4	Thrombosis (Thrombus) 01/2017 - 01/2012
4	Male Infertility (Male Sterility) 01/2017 - 12/2015
4	Carcinogenesis 01/2008 - 08/2005
3	Atherosclerotic Plaque (Atheroma) 05/2022 - 01/2020
3	Pain (Aches) 05/2022 - 04/2012
3	Infertility (Sterility) 01/2022 - 01/2016
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 05/2011
3	COVID-19 01/2021 - 09/2020
3	Acute Coronary Syndrome 01/2021 - 08/2014
3	Coronary Disease (Coronary Heart Disease) 01/2021 - 04/2014
3	Diabetes Mellitus 04/2020 - 04/2014
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 02/2013
3	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2019
3	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2015
3	Seizures (Absence Seizure) 01/2019 - 02/2013
3	Schistosomiasis (Bilharziasis) 01/2017 - 08/2016
3	Chronic Hepatitis B 01/2014 - 07/2013
3	Obesity 12/2013 - 12/2010
2	Pathologic Neovascularization 11/2022 - 01/2020
2	Experimental Arthritis 03/2022 - 06/2016
2	Arthritis (Polyarthritis) 03/2022 - 06/2016
2	Dyspnea (Shortness of Breath) 03/2022 - 09/2020
2	Brain Diseases (Brain Disorder) 01/2022 - 10/2014
2	Pneumonia (Pneumonitis) 01/2022 - 01/2021
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2011
2	Stroke (Strokes) 12/2021 - 01/2017
2	Gout 08/2021 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 05/2021 - 12/2010
2	Infections 02/2021 - 09/2013
2	Fatigue 09/2020 - 01/2019
2	Ischemic Stroke 04/2020 - 02/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2020 - 12/2010
2	Dehydration (Water Stress) 04/2020 - 01/2020
2	Heart Failure 01/2020 - 07/2015

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2005
8	Messenger RNA (mRNA)IBA 01/2022 - 02/2013
7	Pharmaceutical PreparationsIBA 01/2021 - 01/2015
6	LipidsIBA 05/2022 - 03/2015
6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2011
6	MicroRNAs (MicroRNA)IBA 05/2021 - 01/2017
5	Phosphotransferases (Kinase)IBA 11/2022 - 01/2019
5	CytokinesIBA 03/2022 - 07/2006
5	Long Noncoding RNAIBA 01/2022 - 10/2019
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2015
5	Biological ProductsIBA 01/2021 - 01/2015
5	corilaginIBA 01/2019 - 08/2016
4	Cadherins (E-Cadherin)IBA 01/2022 - 01/2019
4	Nonprescription Drugs (Patent Medicines)IBA 01/2021 - 01/2019
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 09/2013
4	Sirolimus (Rapamycin)FDA Link 09/2015 - 01/2012
3	Cholinergic ReceptorsIBA 03/2022 - 01/2020
3	anthrax toxin (anthrax lethal factor)IBA 01/2022 - 11/2015
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2021
3	Dextran SulfateIBA 01/2022 - 01/2021
3	oxidized low density lipoproteinIBA 12/2021 - 08/2014
3	Transcription Factors (Transcription Factor)IBA 06/2021 - 08/2005
3	CarcinogensIBA 01/2021 - 06/2005
3	Antiviral Agents (Antivirals)IBA 01/2021 - 12/2018
3	FructoseIBA 01/2021 - 01/2019
3	Small Interfering RNA (siRNA)IBA 09/2019 - 02/2013
3	InterferonsIBA 12/2018 - 07/2013
3	arseniteIBA 01/2008 - 10/2005
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2022 - 08/2005
2	AntibodiesIBA 03/2022 - 08/2014
2	AntigensIBA 01/2022 - 11/2015
2	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 09/2017
2	CopperIBA 01/2022 - 01/2012
2	CholesterolIBA 12/2021 - 01/2020
2	AutoantibodiesIBA 06/2021 - 01/2020
2	Tyrosine (L-Tyrosine)FDA Link 03/2021 - 04/2011
2	Therapeutic UsesIBA 03/2021 - 01/2017
2	Semaxinib (SU5416)IBA 01/2021 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 02/2018
2	Oxygen (Dioxygen)IBA 04/2020 - 01/2020

Therapy/Procedure

20	Therapeutics 01/2022 - 05/2011
4	Drug-Eluting Stents 09/2014 - 01/2012
3	Percutaneous Coronary Intervention 01/2021 - 08/2014
3	Stents 01/2017 - 01/2012
2	Lasers (Laser) 11/2022 - 01/2022
2	Mastectomy (Mammectomy) 05/2022 - 11/2021
2	Contraindications 01/2022 - 12/2018
2	Precision Medicine 12/2021 - 02/2021
2	Ligation 12/2020 - 01/2018
2	Radiotherapy 01/2020 - 08/2015